头静脉纤维化对2型糖尿病患者动静脉瘘成熟的影响
本研究纳入67例终末期肾病行AVF创建的患者的头静脉组织,用Masson染色检测纤维化,比较糖尿病与非糖尿病组的成熟率。糖尿病组成熟率为45.2%(n=31),非糖尿病组为69.4%(n=36)。T2D、CVF%及术后1月头静脉内径是AVF成熟的独立决定因素。
要点
- 糖尿病组AVF成熟率45.2%,低于非糖尿病组的69.4%。
- T2D、CVF%和术后1月头静脉内径是AVF成熟的独立决定因素。
- 术前静脉直径在两组间无显著差异,校正纤维化和糖尿病状态后非独立因素。
核心结论
- T2D、术后静脉直径减小和头静脉纤维化(CVF%)增加是影响AVF成熟的显著独立危险因素。
- 糖尿病可能主要通过加剧术前头静脉纤维化来损害AVF成熟,纤维化可能限制瘘管创建后的静脉向外重塑和扩张。
研究设计与样本
- 共67例接受AVF创建的终末期肾病患者,分为糖尿病组(n=31)和非糖尿病组(n=36),排除1型糖尿病患者。
- 收集头静脉组织并用Masson染色检测,采用逻辑回归分析识别独立危险因素,ROC曲线分析评估预测价值。
主要发现
- 糖尿病组AVF成熟率为45.2%,非糖尿病组为69.4%。
- 术前静脉直径两组间无显著差异(P > 0.05)。
- T2D组CRP(t = -2.209,P = 0.043)和CVF%(t = -5.295,P < 0.001)显著高于非T2D组。
- T2D组术后1月头静脉内径和PTH(t = 2.412,P = 0.019)显著低于非T2D组。
- 组织病理学分析显示T2D组CVF%(t = -5.067,P < 0.001)显著高于非T2D组。
关键数值与推荐
- 多模型逻辑回归显示T2D、CVF%和术后1月头静脉内径是AVF成熟的独立决定因素。
临床怎么用
- 对于2型糖尿病终末期肾病患者,评估头静脉纤维化(CVF%)可能有助于预测AVF成熟风险。
- 术后1月头静脉内径可作为监测AVF成熟的指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study was to investigate the association between cephalic vein fibrosis and the maturation of arteriovenous fistulas (AVF) in hemodialysis patients with type 2 diabetes (T2D). METHODS: A total of 67 patients with end-stage renal disease (ESRD) undergoing AVF creation were divided into diabetic and nondiabetic cohorts. Individuals with type 1 diabetes were excluded from the study. The cephalic vein tissues were collected and detected using Masson's staining. Logistic regression analysis was performed to identify independent risk factors, and receiver operating characteristic (ROC) curve analysis was utilized to evaluate predictive value. RESULTS: The maturation rate was 45.2% in diabetic group (n = 31) and 69.4% in nondiabetic group (n = 36). Preoperative venous diameter did not significantly differ between groups (P > 0.05). The C-reactive protein (CRP) (t = -2.209, P = 0.043) and the collagen volume fraction (CVF)% (t = -5.295, P < 0.001) in the T2D group were significantly elevated compared to the non-T2D group, whereas the internal diameter of cephalic vein at 1-month postoperation and parathyroid hormone (PTH) (t = 2.412, P = 0.019) in the T2D group were significantly reduced relative to the non-T2D group. Logistic regression analysis across multiple models revealed that T2D, CVF%, and the internal diameter of cephalic vein at 1-month postoperation were independent determinants of AVF maturation. Additionally, histopathological analysis demonstrated that the CVF% (t = -5.067, P < 0.001) was significantly higher in the T2D group compared to the non-T2D group. CONCLUSION: The findings indicated that T2D, reduced postoperative venous diameter, and increased cephalic vein fibrosis (CVF%) were significant independent risk factors affecting AVF maturation. Although preoperative venous diameter is a known clinical predictor, it was not an independent factor in our models after adjusting for fibrosis and diabetes status. Diabetes might impair AVF maturation primarily by exacerbating preoperative cephalic vein fibrosis, which likely restricts venous outward remodeling and expansion after fistula creation.
引用
- Zhao B, Fu G, Zhan S, et al. Exploration of the Influence of Cephalic Vein Fibrosis on the Maturation of Arteriovenous Fistula in Type 2 Diabetes Patients. Ann Vasc Surg. 2026. PMID: 41662966. doi:10.1016/j.avsg.2026.01.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。